TNF-α inhibition using etanercept prevents noise-induced hearing loss by improvement of cochlear blood flow in vivo

References

• Arpornchayanon W., Canis M., Suckfuell M., Ihler F., Olzowy B. et al. 2011. Modeling the measurements of cochlear microcirculation and hearing function after loud noise. Otolaryngol Head Neck Surg, 145, 463–469.
   PubMedGoogle Scholar
• Baker M. & Wayland H. 1974. On-line flow rate and velocity profile measurement for blood in microvessels. Microvasc Res, 7, 131–143.
   PubMed Web of Science ®Google Scholar
• Canis M., Arpornchayanon W., Messmer C., Suckfuell M., Olzowy B. et al. 2010. An animal model for the analysis of cochlear blood flow (corrected) disturbance and hearing threshold in vivo. Eur Arch Otorhinolaryngol, 267, 197–203.
   PubMedGoogle Scholar
• Cohen S., Shoup A., Weisman M.H. & Harris J. 2005. Etanercept treatment for autoimmune inner ear disease: Results of a pilot placebo-controlled study. Otol Neurotol, 26, 903–907.
   PubMed Web of Science ®Google Scholar
• Dai M., Nuttall A., Yang Y. & Shi X. 2009. Visualization and contractile activity of cochlear pericytes in the capillaries of the spiral ligament. Hear Res, 254, 100–107.
   PubMedGoogle Scholar
• Fichtlscherer S., Rossig L., Breuer S., Vasa M., Dimmeler S. et al. 2001. Tumor necrosis factor antagonism with etanercept improves systemic endothelial vasoreactivity in patients with advanced heart failure. Circulation, 104, 3023–3025.
   PubMed Web of Science ®Google Scholar
• Fujioka M., Kanzaki S., Okano H.J., Masuda M., Ogawa K. et al. 2006. Proinflammatory cytokines expression in noise-induced damaged cochlea. J Neurosci Res, 83, 575–583.
   PubMed Web of Science ®Google Scholar
• Heinrich U.R., Selivanova O., Schmidtmann I., Feltens R., Brieger J. et al. 2010. Noise exposure alters cyclooxygenase 1 (COX-1) and 5-lipoxygenase (5-LO) expression in the guinea pig cochlea. Acta Otolaryngol, 130, 358–365.
   PubMed Web of Science ®Google Scholar
• Henderson D., Bielefeld E.C., Harris K.C. & Hu B.H. 2006. The role of oxidative stress in noise-induced hearing loss. Ear Hear, 27, 1–19.
   PubMed Web of Science ®Google Scholar
• Hurlimann D., Forster A., Noll G., Enseleit F., Chenevard R. et al. 2002. Anti-tumor necrosis factor-alpha treatment improves endothelial function in patients with rheumatoid arthritis. Circulation, 106, 2184–2187.
   PubMed Web of Science ®Google Scholar
• Ihler F., Sharaf K.,Bertlich M.,Strieth S.,Reichel C.A. et al. Etanercept prevents decrease of cochlear blood flow dose-dependently caused by Tumor Necrosis Factor-alpha.Ann Otol Rhinol Laryngol, in press.
   Google Scholar
• Keithley E.M., Wang X. & Barkdull G.C. 2008. Tumor necrosis factor alpha can induce recruitment of inflammatory cells to the cochlea. Otol Neurotol, 29, 854–859.
   PubMedGoogle Scholar
• Kim D.H., Park Y.S., Jeon E.J., Yeo S.W., Chang K.H. et al. 2006. Effects of tumor necrosis factor alpha antagonist, platelet activating factor antagonist, and nitric oxide synthase inhibitor on experimental otitis media with effusion. Ann Otol Rhinol Laryngol, 115, 617–623.
   PubMedGoogle Scholar
• Klyscz T., Jünger M., Jung F. & Zeintl H. 1997. Cap image: A new kind of computer-assisted video image analysis system for dynamic capillary microscopy. Biomed Tech Berl, 42, 168–175.
   PubMedGoogle Scholar
• Kono M., Belyantseva I.A., Skoura A., Frolenkov G.I., Starost M.F. et al. 2007. Deafness and stria vascularis defects in S1P2 receptor-null mice. J Biol Chem, 282, 10690–10696.
   PubMed Web of Science ®Google Scholar
• Le Prell C.G., Yamashita D., Minami S.B., Yamasoba T. & Miller J.M. 2007. Mechanisms of noise-induced hearing loss indicate multiple methods of prevention. Hear Res, 226, 22–43.
   PubMed Web of Science ®Google Scholar
• Lobo D., Trinidad A., Garcia-Berrocal J.R., Verdaguer J.M. & Ramirez- Camacho R. 2006. TNFalpha blockers do not improve the hearing recovery obtained with glucocorticoid therapy in an autoimmune experimental labyrinthitis. Eur Arch Otorhinolaryngol, 263, 622–626.
   PubMedGoogle Scholar
• Matteson E.L., Choi H.K., Poe D.S., Wise C., Lowe V.J. et al. 2005. Etanercept therapy for immune-mediated cochleovestibular disorders: A multi-center, open-label, pilot study. Arthritis Rheum, 53, 337–342.
   PubMed Web of Science ®Google Scholar
• Miller J.M., Brown J.N. & Schacht J. 2003. 8-iso-prostaglandin F(2alpha), a product of noise exposure, reduces inner ear blood flow. Audiol Neurootol, 8, 207–221.
   PubMed Web of Science ®Google Scholar
• Nakai Y. & Masutani H. 1988. Noise-induced vasoconstriction in the cochlea. Acta Otolaryngol Suppl, 447, 23–27.
   PubMedGoogle Scholar
• Nuttall A.L. 1987. Techniques for the observation and measurement of red blood cell velocity in vessels of the guinea pig cochlea. Hear Res, 27, 111–119.
   PubMed Web of Science ®Google Scholar
• Nuttall A.L. 1987. Velocity of red blood cell flow in capillaries of the guinea pig cochlea. Hear Res, 27, 121–128.
   PubMed Web of Science ®Google Scholar
• Nuttall A.L. 1999. Sound-induced Cochlear ischemia/hypoxia as a mechanism of hearing loss. Noise Health, 2, 17–32.
   PubMedGoogle Scholar
• Psillas G., Pavlidis P., Karvelis I., Kekes G., Vital V. et al. 2008. Potential efficacy of early treatment of acute acoustic trauma with steroids and piracetam after gunshot noise. Eur Arch Otorhinolaryngol, 265, 1465–1469.
   PubMed Web of Science ®Google Scholar
• Satoh H., Firestein G.S., Billings P.B., Harris J.P. & Keithley E.M. 2002. Tumor necrosis factor-alpha, an initiator, and etanercept, an inhibitor of cochlear inflammation. Laryngoscope, 112, 1627–1634.
   PubMed Web of Science ®Google Scholar
• Scherer E.Q., Lidington D., Oestreicher E., Arnold W., Pohl U. et al. 2006. Sphingosine-1-phosphate modulates spiral modiolar artery tone: A potential role in vascular-based inner ear pathologies?Cardiovasc Res, 70, 79–87.
   PubMedGoogle Scholar
• Scherer E.Q., Yang J., Canis M., Reimann K., Ivanov K. et al. 2010. Tumor necrosis factor-alpha enhances microvascular tone and reduces blood flow in the cochlea via enhanced sphingosine-1-phosphate signaling. Stroke, 41, 2618–2624.
   PubMedGoogle Scholar
• Shi X. 2009. Cochlear pericyte responses to acoustic trauma and the involvement of hypoxia-inducible factor-1alpha and vascular endothelial growth factor. Am J Pathol, 174, 1692–1704.
   PubMedGoogle Scholar
• Shi X. 2011. Physiopathology of the cochlear microcirculation. Hear Res, 282, 10–24.
   PubMed Web of Science ®Google Scholar
• Tabuchi K., Murashita H., Sakai S., Hoshino T., Uemaetomari I. et al. 2006. Therapeutic time window of methylprednisolone in acoustic injury. Otol Neurotol, 27, 1176–1179.
   PubMed Web of Science ®Google Scholar
• Thalmann R., Miyoshi T. & Thalmann I. 1972. The influence of ischemia upon the energy reserves of inner ear tissues. Laryngoscope, 82, 2249–2272.
   PubMedGoogle Scholar
• Tornabene S.V., Sato K., Pham L., Billings P. & Keithley E.M. 2006. Immune cell recruitment following acoustic trauma. Hear Res, 222, 115–124.
   PubMedGoogle Scholar
• Wang X., Truong T., Billings P.B., Harris J.P. & Keithley E.M. 2003. Blockage of immune-mediated inner-ear damage by etanercept. Otol Neurotol, 24, 52–57.
   PubMed Web of Science ®Google Scholar
• Zeintl H., Sack F.U., Intaglietta M. & Messmer K. 1989. Computer assisted leukocyte adhesion measurement in intravital microscopy. Int J Microcirc Clin Exp, 8, 293–302.
   PubMedGoogle Scholar